Announced Tue, 28 Jul · 10:47 IST
Board Meeting on Aug 7 to approve Q1 FY27 results
Results View source PDF
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Aarti Pharmalabs has informed BSE and NSE that its Board of Directors will meet on Friday, August 7, 2026, to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter ended June 30, 2026, along with the auditors' limited review reports. The trading window for insiders remains closed from July 1, 2026 until August 9, 2026.
Likely market impact
Routine procedural filing; Q1 FY27 earnings expected around August 7-8, 2026. Watch for actual results.